Amiodaron-induced thyroid dysfunction: pathogenesis, diagnosis, treatment


Cite item

Full Text

References

  1. Connolly S. J. Evidence-based analysis of amiodarone efficacy and safety. Circulation 1999; 100: 2025-2034.
  2. Голицын С. Г. Принципы фармакотерапии желудочковых нарушений ритма сердца. Клин, фармакол. и тер. 1997; 6 (3): 14-16.
  3. Голицын С. П. Грани пользы и риска в лечении желудочковых нарушений ритма сердца. Международ, журн. мед. практики 2000; 10: 56-64.
  4. Singh В. N., Vencatesh N., Kannan R. et al. The historical development, cellular electrophysiology and pharmacology of amiodarone. Progr. Cardiovasc. Dis. 1989; 31 (4): 249-280.
  5. Burkart F., Pfisterer M., Kiowski W. et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhytmic Study on Infarct Survival (BASIS). J. Am. Coll. Cardiol. 1990; 16; 1711-1718.
  6. Ceremuzynski L., Kleczar E., Krzeminska-Pacula M. et al. The effect of amiodarone on mortality after myocardial infarction double blind, placebo controlled, pilot study. Ibid. 1992; 20: 1056-1062.
  7. Boutitie F., Boissel J.-P., Connolly S. J. et al. Amiodarone interaction with p-blockers. Analysis of merged EMIAT and CAMIAT databases. Circulation 1999; 99: 2268-2275.
  8. Cairns J. A., Connolly S. J., Roberts R. et al. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarization: CAMIAT. Lancet 1997; 349: 675-682.
  9. Braverman Lewis E., Roti E. Disease of the thyroid. Totowa, New Jersy: Humana press; 1997. 401-413.
  10. Wiersinga W. W. Amiodarone and the thyroid. In: Weetman A. P., Grossman A., eds. Pharmacotherapeutics of the thyroid gland. Berlin: Springer-Verlag; 1997. 225-287.
  11. Стокигт Ж. Р. Влияние лекарственных препаратов на функцию щитовидной железы. Thyroid intern. 2000; 2: 4- 13.
  12. Сингер П., Гершман Д. Болезни щитовидной железы. В кн.: Лавин Н. (ред.) Эндокринология. М.: Практика; 1999. 536-550.
  13. Loh К. Amiodarone-induced thyroid disorders: clinical review. Postgrad. Med. J. 2000; 76: 133-140.
  14. Bogazzi F., Bartalena L., Martino E. et al. The various effects of amiodarone on thyroid function. Thyroid 2001; 11 (5): 511-519.
  15. Drexhage H. A., de Wit H. J., Mooij P. Iodine and thyroid autoimmune disease. In: The thyroid and environment: Merck European thyroid symposium. Budapest; 2000. 22-25.
  16. Longer P. Increased iodine intake and autoimmune thyreoiditis: exclamation and question marks, facts and myth. Thyroid Gland 1996; 1: 3-17.
  17. Foresti V., Pepe R., Parisio E. et al. Antithyroid antibodies during amiodarone treatment. Acta Endocrinol. (Kbh.). 1989; 121: 203-206.
  18. Safran M., Martino E., Aghini-Lombardi F. et al. Effect of amiodarone on circulating antithyroid antibodies. Br. Med. J. 1988; 297: 456-457.
  19. Di Matola Т., D'Ascoli F., Fenzi G. et al. Amiodarone induces cytochrome С release and apoptosis through an iodine-independent mechanism. J. Clin. Endocrinol. Metab. 2000; 85 (11): 4323-4330.
  20. Di Matola Т., Vitale M., Fenzi G. et al. Iodine excess induces apoptosis in thyroid cells through a p53-independent mechanism involving oxidative stress. J. Endocrinol. 2000; 141 (2): 598-605.
  21. Chiovato E., Santiti F., Pinchera А. Лечение гипертиреоза. Тироид Россия 1997; 1: 27-38.
  22. Newman С. М., Price A., Davies D. W. et al. Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy. Heart 1998; 79: 121-127.
  23. Beddows S. A., Page S. R., Taylor A. H. et al. Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes. Biochem. Pharmacol. 1989; 38: 4397-4403.
  24. Cappiello E., Boldorini R., Tosoni A. et al. Ultrastructural evidence of thyroid damage in amiodarone-induced thyrotoxicosis. J. Endocrinol. Invest. 1995; 18 (11): 862-868.
  25. Bartalena E., Grasso E., Brogioni S. et al. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J. Clin. Endocrinol. Metab. 1994; 78 (2): 423-427.
  26. Bauters С., d'Herbomes М., Nocaudie M. et al. IL-6 and radioactive iodine uptake in patiens with amiodaron-induced thyrotoxicosis. J. Endocrinol. Invest. 1999; 22 (6, suppl.): 94.
  27. Wolff J. Perchlorate and the thyroid gland. Pharmacol. Rev. 1998; 50: 89-105.
  28. Dikstein G., Shechner C., Adai F. et al. Lithium treatment in amiodarone-induced thyrotoxicosis. Am. J. Med. 1997; 102: 454-458.
  29. Meurisse M., Hamoir E., D'Silva M. et al. Amiodarone - induced thyrotoxicosis: is there a place for surgery? Wld J. Surg. 1993; 17: 622-621.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2003 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies